#Abs0588 Effectiveness of TNFi vs non-TNFis in obese patients with #rheumatic disease @MilenaGianfran:
👉🏼>16000pts @ACRheum RISE
👉🏼Abatacept➡️larger decreases in CDAI in obese pts
👉🏼Tocilizumab➡️larger decreases in CDAI in non-obese pts
@RheumNow #ACR21
https://t.co/bL5xnG1iNh
Links:
Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Pa…
https://acrabstracts.org/abstract/effectiveness-of-tnfi-versus-non-tnfi-biologi…
07-11-2021